StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) stock

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.97−0.03 (-3.47%)

Close on Nov 18, 2026Market cap $134.14MP/E –Yield –

ALX Oncology profit margin

Profit margin (net margin) is net income as a percentage of revenue.

ALX Oncology's profit margin for the twelve months ending Dec 31, 2020 was -3869.7%. For fiscal 2020 it was -3869.7%, against -401.2% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-3869.7%−3468.5
FY2019Dec 31, 2019-401.2%+263.1
FY2018Dec 31, 2018-664.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2020Jun 30, 2020-2150.1%−1826.0
Q1 FY2020Mar 31, 2020-832.7%–
Q4 FY2019Dec 31, 2019-640.1%–
Q3 FY2019Sep 30, 2019-242.4%–
Q2 FY2019Jun 30, 2019-324.1%–

More ALX Oncology figures

See a number that looks wrong?